I G.A. Wiradari Tedja, Jusak Nugraha, Betty Agustina Tambunan, Fransisca Sri Oetami


Tuberculosis (TB), an infectious disease caused by a Mycobacterium tuberculosis, is still a health problem in Indonesia, and the world. One of the failures to control the TB epidemic is due to the lack of effective vaccines available today. Protective immune responses to M.tuberculosis are dominated by cellular immunity and less by humoral immunity. IFN-γ, and IL-10 play a role in the protection of against M.tuberculosis, and the pathogenesis of TB. Fusion antigen ESAT-6-CFP-10 has a strong antigenicity to T cells and stimulates specific cellular immune responses, thereby providing benefit in immune responses that are protective against M.tuberculosis infection. The aimed of this study was to know the difference betwen IFN-γ, and IL-10 levels on PBMC culture of active TB, latent TB, and healthy people after ESAT-6-CFP-10 fusion antigen stimulation. This study used an in vitro of quasi experimental design in PBMC cultures of active TB, latent TB, and healthy people groups stimulated by ESAT-6-CFP-10 antigen fusion Mycobacterium tuberculosis. IFN-γ, and IL-10 levels were measured by ELISA method. The results were analyzed by one-way ANOVA. The mean levels of IFN-γ post-stimulation of ESAT-6-CFP-10 fusion antigens did not differ (p=0.359) in the active pulmonary TB group (0.07 - 2114), latent TB (6.84 - 1381) and healthy people 1.88 - 1807.70), as well as the mean levels of IL-10 (p=0.712) in the active pulmonary TB (16.70 - 328.80), latent TB (29.70 - 323.60 ) and healthy people (31.30 - 958). There were no significant differences in levels of IFN-γ and IL-10 in active TB, latent TB, and healthy people after stimulation by fusion antigen ESAT-6-CFP-10.



Tuberculosis, interferon gamma, interleukin-10, fusion antigen ESAT-6-CFP-10 after-transfusion.

Full Text:



Kemenkes Republik Indonesia 2015. Profil Kesehatan Indonesia 2015. Available at Diunduh tanggal 1 Januari 2015

Ahmad S. Review: Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection. Clinical, and Developmental Immunology. 2010; 2011: 1-17

Herrera V, Perry S, Parsonnet J, Banaei N. Clinical Application, and Limitations of Interferon-γ Release Assays for the Diagnosis of Latent Tuberculosis Infection. Clinical Infectious Disease. 2011; 52(8): 1031-37

Keyser ED, Keyser FD, Baets FD. Tuberculin Skin Test versus Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis Infection. Acta Clinica Belgia. 2014; 69(5): 358-67

Gyoung HY, Stolinska PG, Smith AB, Lalor MK, Chaguluka S, et al. Combination of Cytokine Responses Indicative of Latent TB, and Active TB in Malawian Adults. Plos One. 2013; 8(11): 1-10

O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. The Immune Response in Tuberculosis. The Annual Review of Immunology. 2013; 31: 475-527

Xu JN, Chen JP, Chen DL. Serodiagnosis Efficacy and Immunogenicity of the Fusion Protein of Mycobacterium tuberculosis Composed of the 10—Kilodalton Culture Filtrate Protein, ESAT-6, and the Extracellular Domain Fragment of PPE68. Clinical, and Vaccine Immunology. 2012; 19(4): 536-544

Mustafa AS. Mini Review: Diagnostic and Vaccine Potentials of ESAT-6 Family Proteins Encoded by M. tuberculosis Genomic Regions Absent in M. bovis BCG. J Mycobacterial Diseases. 2013; 3(2): 1-5

Yuk JM, Jo EK. Review article: Host Immune Responses to Mycobacterial Antigens and Their Implications for the Development of Vaccine to Control Tuberculosis. Clinical Experimental Vaccine Research. 2014; 4(3): 155-167

Nikokar I, Makvandi M, Kajbaf MJ, Farajzadeh A, Mirsaeidi M, et al. Evaluation of Cellular Immune Respons Against Purified Antigen 85 in Patients with Tuberculosis. Iran Journal Immunology. 2006; 3(2): 70-77

Fillon LG, Al-Ahdal MN, Tetro JA. Review: Vaccines against Mycobacterium tuberculosis : Exploring Alternate Strategies to Combat a Near-perfect Pathogen. J Mycobacterial Disease. 2013; 1-9

Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, and Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice, Journal of Experimental Medicine, 1993; 178(6): 2243–47

Flynn JL, Chan J, Triebold KJ, Dalton DK,. Stewart TA, and Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection, Journal of Experimental Medicine, 1993; 178 (6): 2249–2254

Cavalcanti YVN, Brelaz MCA, Neves JK, Ferraz JC, Pereira VRA. Review: Role of TNF-Alpha, IFN-Gamma,

and IL-10 in the Development of Pulmonary Tuberculosis. Hindawi Publishing Corporation. Pulmonary Medicine. 2012; 2012: 1-10.

Kassa D, Ran L, Geberemeskel W, Tebeje M, Alemu A, et al. Analysis of Immune Responses against a Wide Range of Mycobacterium tuberculosis Antigens in Patients with Active Pulmonary Tuberculosis. Clinical, and Vaccine Immunology, 2012; 19(12): 1907-1915.

Redford PS, Murray PJ, O’Garra A. The Role of IL-10 in Immune Regulation During M.tuberculosis Infection. Mucosal Immunology. Nature Publishing Group. 2011; 4(3): 261-270.

WHO, 2015. Global Tuberculosis report 2015. WHO, Geneva, Switzerland. Diunduh tanggal 1 Januari 2015.

Surcel HM, Troye-Blomberg M, Paulline S. Th1/Th2 profiles in tuberculosis, based on proliferation, and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 1994; 81(2): 171-176

Maderuelo DL, Arnalich F, Serantes R, Gonzales A, Codoceo R, Madero R. Interferon gamma, and interleukin-10 gene Polymorphisms in Pulmonary tuberculosis. Am J Respir Crit Care Med. 2003; 167: 970-975.Chandra RK. Nutrition, immunity, and infection : From basknowledge of dietary manipulation of immune responses to practical application of ameliorating suffering, and improving survival. Proc Natl Acad Sci USA. 1996; 93: 14304 – 7.

Joshi L, Ponnana M, Sivangala R, Chelluri LK, Nallari P, Penmetsa S, et al. Evaluation of TNF-α, IL-10 and IL-6 cytokine production and their correlation with Genotype variants amongst Tuberculosis patients and their Household Contacts. Plos one, 2015; 10(9): 1-15. Doi: 10.1371/journal.pone.0137727.

Olobo JO, Geletu M, Demissie A, Eguale T, Hiwot K, Aderaye G, Britton S.Circulating TNF-a, TGFß



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.